Medication info
Raberitun Tablet 20 mg (Rabeprazole Sodium)

Raberitun Tablet 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Jeongwoo Pharmaceutical Co., Ltd.
Appearance
Pale yellow round enteric-coated tablet
Packaging
28 tablets/Alu-Alu (14 tablets/Alu-Alu * 2)
Approval status
Active

MFDS item code 201603763 · Approved 2016.06.22

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including combination therapy for eradication), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is limited to patients with confirmed severe mucosal damage. Symptom relief in gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled as needed using on-demand therapy with 10 mg once daily. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended to administer this medication 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medication for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Elderly patients Administer with caution because hepatic function is often reduced.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Jeongwoo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including combination therapy for eradication), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This drug is used to treat gastric ulcers and duodenal ulcers, and it is also utilized to alleviate symptoms of erosive or ulcerative gastroesophageal reflux disease. Additionally, it is effective for long-term maintenance therapy of gastroesophageal reflux disease, and is used in combination with antibiotics to treat gastrointestinal ulcers infected with Helicobacter pylori. It can also improve conditions with excessive gastric acid secretion such as Zollinger-Ellison syndrome. This medication is broadly used for various gastrointestinal disorders to alleviate symptoms and aid in treatment.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is limited to patients with confirmed severe mucosal damage. Symptom relief in gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled as needed using on-demand therapy with 10 mg once daily. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended to administer this medication 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medication for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Elderly patients Administer with caution because hepatic function is often reduced.

Child dose

Safety in children has not been established.

Precautions

This medication should not be used by patients with specific allergic reactions, pregnant women, or breastfeeding women. Patients with poor liver function, the elderly, and those with allergies to specific dyes should use this medication with caution. If allergy symptoms such as skin rash or itching occur while taking this medication, discontinuation should be immediate. Regular blood tests and liver function tests are required, and if any abnormalities are found, immediate consultation with a physician is necessary. Side effects may occur in various systems including the heart, gastrointestinal tract, nervous system, respiratory system, and skin, so careful observation is needed if symptoms arise. Due to the drug's action of inhibiting gastric acid secretion, long-term use may increase the risk of bone fractures, therefore, long-term use should be according to a physician's directions. Additionally, long-term use may lower magnesium levels, so regular blood tests for monitoring are necessary. There may be an increased risk of gastrointestinal bacterial infections, so if symptoms such as diarrhea or abdominal pain persist, notify a healthcare professional immediately. Caution is required as drowsiness or dizziness may occur while driving or operating machinery. There may be interactions with other medications taken with this drug, so it is essential to inform the physician or pharmacist of any current medications. It is safest not to use this medication during pregnancy or breastfeeding. It is advisable not to use in children as safety has not been established. There are no specific antidotes for overdose, so in case of suspicion, immediately visiting a medical facility for appropriate treatment is necessary. Tablets should be swallowed whole, not chewed or crushed, and kept out of the reach of children. For long-term use of this medication, regular medical examinations and tests as necessary are important.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechial hemorrhage, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, atrioventricular block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, prolonged QTc interval, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stool, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, hyperphagia, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste abnormalities, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, asthenia, neuroirritability, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, muscle flaccidity of the limbs, tactile hypesthesia, decreased grip strength, language disorder, staggering, delirium, disorientation, somnolence, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthropathy, bursitis, hypertonia, neuralgia, single contraction, sweating, alopecia, skin dryness, shingles, psoriasis, skin color change, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, epididymitis, urinary incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, loss of appetite, neck stiffness, photosensitivity reactions, hangover effect, weight loss, gout, anaphylaxis, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, vesicular skin rash, urticarial skin rash, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, systemic lupus erythematosus reported in post-marketing studies, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. A storage temperature of 1 to 30 degrees Celsius is recommended. By storing it this way, the drug's effectiveness and safety can be preserved for a long time.

Appearance and packaging

Appearance

Pale yellow round enteric-coated tablet

Package unit

28 tablets/Alu-Alu (14 tablets/Alu-Alu * 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.